Bruce Koch

Director, High-Throughput Screening, Sarafan ChEM-H
Mail Code: none

Dr. Koch obtained his PhD at Harvard Medical School working on GPCR signaling mechanisms activated by the neuropeptide somatostatin. He did a postdoc in Randy Schekman’s lab at UC Berkeley working on the role of heat shock proteins in protein secretion. During his career, Dr. Koch spent 19 years in the pharmaceutical industry, working first at Syntex and later at Roche, where he became Director of Discovery Technologies for the Roche Palo Alto Site and Global Coordinator of High Throughput Screening. At Stanford, he also serves as the Director of the Sarafan ChEM-H/Chemical and Systems Biology High Throughput Screening Knowledge Center. In that role, he mentors trainees working on small molecule lead discovery projects, with a special emphasis on those that use biochemical screening assays. He is also an advisor to the SPARK Program at Stanford.